Drug Shortage Report for LOVENOX
Report ID | 136137 |
Drug Identification Number | 02236883 |
Brand name | LOVENOX |
Common or Proper name | Lovenox |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ENOXAPARIN SODIUM |
Strength(s) | 40MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 10 |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-12-17 |
Actual start date | |
Estimated end date | 2021-12-20 |
Actual end date | 2021-12-02 |
Shortage status | Avoided shortage |
Updated date | 2021-12-02 |
Company comments | Transportation delay and overselling is leading to a limited supply of product. Allocation will be kept in place to mitigate the anticipated shortage. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v56 | 2021-12-02 | French | Compare |
v55 | 2021-12-02 | English | Compare |
v54 | 2021-11-23 | French | Compare |
v53 | 2021-11-23 | English | Compare |
v52 | 2021-11-18 | French | Compare |
v51 | 2021-11-18 | English | Compare |
v50 | 2021-11-16 | English | Compare |
v49 | 2021-11-10 | French | Compare |
v48 | 2021-11-10 | English | Compare |
v47 | 2021-11-05 | English | Compare |
v46 | 2021-10-27 | French | Compare |
v45 | 2021-10-27 | English | Compare |
v44 | 2021-10-27 | French | Compare |
v43 | 2021-10-27 | English | Compare |
v42 | 2021-10-08 | French | Compare |
v41 | 2021-10-08 | English | Compare |
v40 | 2021-09-30 | French | Compare |
v39 | 2021-09-30 | English | Compare |
v38 | 2021-09-21 | French | Compare |
v37 | 2021-09-21 | English | Compare |